Brookfield Marks 80 Years of Laboratory Technology
PTSM: Pharmaceutical Technology Sourcing and Management
Brookfield continues to supply viscometers and rheometers for laboratory and on-line process control applications.
Brookfield Engineering announced its 80th year of supplying viscometers and rheometers for laboratory and on-line process control applications. Over the past 80 years, Brookfield Engineering has developed technologies to address issues regarding temperature control, small sample volumes, and low viscosities. These technologies include a range of digital and programmable viscometers and rheometers that operate in stand-alone or PC control modes. Brookfield also developed a variety of in-line process viscometers that enable manufacturers to measure viscosity continuously during production.
Some of Brookfield's technologies include the CT3 Texture Analyzer, a line of R&D and QC testing instrumentation, and the PFT Powder Flow Tester, which provides analysis of powder flow behavior in industrial equipment. Most recently, Brookfield has added touch screen technology to several of their instruments. Brookfield is headquartered in Middleboro, MA, with additional offices in England and Germany.
Source: Brookfield Engineering
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
